Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults.

about

Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis.

P2860

Q52367873-A37B9FC8-3F56-44D7-B29B-A3639C1F40E7

P2860

Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults.

Item

http://www.wikidata.org/entity/Q47093829

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Economic Evaluation of Dupilum ...... e Atopic Dermatitis in Adults.

@en

Economic Evaluation of Dupilum ...... e Atopic Dermatitis in Adults.

@nl

type

Item

label

Economic Evaluation of Dupilum ...... e Atopic Dermatitis in Adults.

@en

Economic Evaluation of Dupilum ...... e Atopic Dermatitis in Adults.

@nl

prefLabel

Economic Evaluation of Dupilum ...... e Atopic Dermatitis in Adults.

@en

Economic Evaluation of Dupilum ...... e Atopic Dermatitis in Adults.

@nl

P1476

Economic Evaluation of Dupilum ...... e Atopic Dermatitis in Adults.

@en

P2093

Abhijit Gadkari

http://www.w3.org/2001/XMLSchema#string

Andreas Kuznik

http://www.w3.org/2001/XMLSchema#string

Christopher N Graham

http://www.w3.org/2001/XMLSchema#string

Eric Simpson

http://www.w3.org/2001/XMLSchema#string

Gaëlle Bégo-Le-Bagousse

http://www.w3.org/2001/XMLSchema#string

LaStella Miles

http://www.w3.org/2001/XMLSchema#string

Laurent Eckert

http://www.w3.org/2001/XMLSchema#string

Puneet Mahajan

http://www.w3.org/2001/XMLSchema#string

Sean D Sullivan

http://www.w3.org/2001/XMLSchema#string

Vera Mastey

http://www.w3.org/2001/XMLSchema#string

P2860

EuroQol--a new facility for the measurement of health-related quality of life

Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States.

Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.

A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy.

The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries

Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.

The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization.

The psychosocial burden of childhood atopic dermatitis.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Etanercept and efalizumab for the treatment of psoriasis: a systematic review.

P2888

s13555-017-0201-6

P304

493-505

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13555-017-0201-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28933010

http://www.w3.org/2001/XMLSchema#string

P932

5698200

http://www.w3.org/2001/XMLSchema#string

Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults.

about

P2860

P2860

Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932